Literature DB >> 26965292

Resting pulmonary artery pressure of 21-24 mmHg predicts abnormal exercise haemodynamics.

Edmund M T Lau1, Laurent Godinas2, Olivier Sitbon3, David Montani3, Laurent Savale3, Xavier Jaïs3, Frederic Lador4, Sven Gunther3, David S Celermajer5, Gérald Simonneau3, Marc Humbert3, Denis Chemla6, Philippe Herve7.   

Abstract

A resting mean pulmonary artery pressure (mPAP) of 21-24 mmHg is above the upper limit of normal but does not reach criteria for the diagnosis of pulmonary hypertension (PH). We sought to determine whether an mPAP of 21-24 mmHg is associated with an increased risk of developing an abnormal pulmonary vascular response during exercise.Consecutive patients (n=290) with resting mPAP <25 mmHg who underwent invasive exercise haemodynamics were analysed. Risk factors for pulmonary vascular disease or left heart disease were present in 63.4% and 43.8% of subjects. An abnormal pulmonary vascular response (or exercise PH) was defined by mPAP >30 mmHg and total pulmonary vascular resistance >3 WU at maximal exercise.Exercise PH occurred in 74 (86.0%) out of 86 versus 96 (47.1%) out of 204 in the mPAP of 21-24 mmHg and mPAP <21 mmHg groups, respectively (OR 6.9, 95% CI: 3.6-13.6; p<0.0001). Patients with mPAP of 21-24 mmHg had lower 6-min walk distance (p=0.002) and higher New York Heart Association functional class status (p=0.03). Decreasing levels of mPAP were associated with a lower prevalence of exercise PH, which occurred in 60.3%, 38.7% and 7.7% of patients with mPAP of 17-20, 13-16 and <13 mmHg, respectively.In an at-risk population, a resting mPAP between 21-24 mmHg is closely associated with exercise PH together with worse functional capacity.
Copyright ©ERS 2016.

Entities:  

Mesh:

Year:  2016        PMID: 26965292     DOI: 10.1183/13993003.01684-2015

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  13 in total

Review 1.  Translational Advances in the Field of Pulmonary Hypertension. Focusing on Developmental Origins and Disease Inception for the Prevention of Pulmonary Hypertension.

Authors:  Bradley A Maron; Steven H Abman
Journal:  Am J Respir Crit Care Med       Date:  2017-02-01       Impact factor: 21.405

2.  Metabolomics of exercise pulmonary hypertension are intermediate between controls and patients with pulmonary arterial hypertension.

Authors:  Jason L Sanders; Yuchi Han; Mariana F Urbina; David M Systrom; Aaron B Waxman
Journal:  Pulm Circ       Date:  2019-10-30       Impact factor: 3.017

Review 3.  Potential role of exercise echocardiography and right heart catheterization in the detection of early pulmonary vascular disease in patients with systemic sclerosis.

Authors:  Gabor Kovacs; Horst Olschewski
Journal:  J Scleroderma Relat Disord       Date:  2019-05-24

4.  Pulmonary Vascular and Right Ventricular Burden During Exercise in Interstitial Lung Disease.

Authors:  Rudolf K F Oliveira; Aaron B Waxman; Paul J Hoover; Paul F Dellaripa; David M Systrom
Journal:  Chest       Date:  2020-03-12       Impact factor: 9.410

5.  Exercise Pulmonary Hypertension Predicts Clinical Outcomes in Patients With Dyspnea on Effort.

Authors:  Jennifer E Ho; Emily K Zern; Emily S Lau; Luke Wooster; Cole S Bailey; Thomas Cunningham; Aaron S Eisman; Kathryn M Hardin; Robyn Farrell; John A Sbarbaro; Mark W Schoenike; Nicholas E Houstis; Aaron L Baggish; Ravi V Shah; Matthew Nayor; Rajeev Malhotra; Gregory D Lewis
Journal:  J Am Coll Cardiol       Date:  2020-01-07       Impact factor: 24.094

6.  Under Pressure to Clarify Pulmonary Hypertension Clinical Risk.

Authors:  Bradley A Maron; Bradley M Wertheim; Mark T Gladwin
Journal:  Am J Respir Crit Care Med       Date:  2018-02-15       Impact factor: 30.528

7.  Kinetics of Cardiac Output at the Onset of Exercise in Precapillary Pulmonary Hypertension.

Authors:  Frédéric Lador; Aurélien Bringard; Samir Bengueddache; Guido Ferretti; Karim Bendjelid; Paola M Soccal; Stéphane Noble; Maurice Beghetti; Denis Chemla; Philippe Hervé; Olivier Sitbon
Journal:  Biomed Res Int       Date:  2016-11-20       Impact factor: 3.411

8.  Treatment of exercise pulmonary hypertension improves pulmonary vascular distensibility.

Authors:  William D Wallace; Mehdi Nouraie; Stephen Y Chan; Michael G Risbano
Journal:  Pulm Circ       Date:  2018-06-19       Impact factor: 3.017

9.  Functional impact of exercise pulmonary hypertension in patients with borderline resting pulmonary arterial pressure.

Authors:  Rudolf K F Oliveira; Mariana Faria-Urbina; Bradley A Maron; Mario Santos; Aaron B Waxman; David M Systrom
Journal:  Pulm Circ       Date:  2017-06-08       Impact factor: 3.017

10.  Understanding exercise hemodynamics.

Authors:  Horst Olschewski
Journal:  Pulm Circ       Date:  2017 Jul-Sep       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.